IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here.
Company: Omeros
Symbol: OMER
Price: Last trade $20.04
Trade Date: 1/29
Shares: 2.5 million
Underwriter(s) Cowen & Co.
Rating=Subscribe for Rating!
Company: Five Prime Therapeutics-BLOCK
Symbol: FPRX
Price: Last trade $27.01
Trade Date: 1/29
Shares: 1.1 million
Underwriter(s) Morgan Stanley
Rating=Subscribe for Rating!
Company: Mirati Therapeutics
Symbol: MRTX
Price: Last trade $20.46
Trade Date: 1/29
Shares: 1.7 million
Underwriter(s) Citigroup, Jefferies, Leerink Swann
Rating=Subscribe for Rating!
Company: Rexford Industrial Realty, Inc.
Symbol: REXR
Price: Last trade $16.46
Trade Date: 1/29
Shares: 10 million
Underwriter(s) BofA Merrill Lynch, Citigroup, J.P. Morgan, Wells Fargo Securities, Jefferies
Rating=Subscribe for Rating!
Company: Oxford Immunotec Global PLC
Symbol: OXFD
Price: Last trade $13.32
Trade Date: 1/30
Shares: 3.75 million
Underwriter(s) J.P. Morgan, Piper Jaffray
Co Manager(s) Cowen & Co, Robert Baird
Rating=Subscribe for Rating!
Company: Performant Financial Corporation
Symbol: PFMT
Price: Last trade $5.86
Trade Date: 1/30
Shares: 8.5 million
Underwriter(s) Morgan Stanley, SunTrust Robinson Humphrey
Rating=Subscribe for Rating!